In cancer, stress-enhanced EVs secretion has been associated with increased tumor aggressiveness, through the delivery of oncogenic proteins, TGF-β, and immunomodulatory miRNAs that promote stromal remodeling and immune evasion [35]. The gene discussed is TGFB1; the disease is cancer.